<ARTICLE>                              5
<RESTATED>
<MULTIPLIER>                           1,000
       
                                    
<PERIOD-TYPE>                          6-MOS
<FISCAL-YEAR-END>                      DEC-31-1997
<PERIOD-END>                           JUN-30-1997
<CASH>                                   1,853,011
<SECURITIES>                               100,138
<RECEIVABLES>                            1,449,845
<ALLOWANCES>                                62,019
<INVENTORY>                                945,831
<CURRENT-ASSETS>                         4,992,080
<PP&E>                                   7,039,912
<DEPRECIATION>                           2,883,445
<TOTAL-ASSETS>                          12,288,903
<CURRENT-LIABILITIES>                    3,699,847
<BONDS>                                  2,501,817
<PREFERRED-MANDATORY>                            0
<PREFERRED>                                      0
<COMMON>                                   355,564
<OTHER-SE>                               4,314,379
<TOTAL-LIABILITY-AND-EQUITY>            12,288,903
<SALES>                                  3,724,943
<TOTAL-REVENUES>                         3,941,728
<CGS>                                      929,557
<TOTAL-COSTS>                            1,090,131
<OTHER-EXPENSES>                         4,115,329<F16>
<LOSS-PROVISION>                                 0<F17>
<INTEREST-EXPENSE>                         123,090
<INCOME-PRETAX>                           (712,096)
<INCOME-TAX>                               587,384
<INCOME-CONTINUING>                     (1,299,480)
<DISCONTINUED>                                   0
<EXTRAORDINARY>                                  0
<CHANGES>                                        0
<NET-INCOME>                            (1,299,480)
<EPS-PRIMARY>                                (1.18)
<EPS-DILUTED>                                (1.19)
<FN>
<F16>-Amounts include research and development, selling and
      general administrative expenses, and asset impairment.
<F17>-The information called for is not given as the balances
      are not individually significant.
</FN>